Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Atacand - labeled renal guidance
Product / population
Candesartan (Atacand), adult oral tablets for hypertension
Renal method
Clinical renal category or population named in the cited section
Source revision
DailyMed SPL version 5, effective 2025-12-22; posted Dec 23, 2025
DailyMed / product prescribing information · Candesartan (Atacand), adult oral tablets for hypertension
Renal method: Clinical renal category or population named in the cited section Source date: DailyMed SPL version 5, effective 2025-12-22; posted Dec 23, 2025 Retrieved: 2026-11-07
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Renal guidance: 2 and clinical pharmacology, renal insufficiency
Renal insufficiency alone does not require a lower initial adult dose. Check for volume depletion when selecting the starting dose. Monitor renal function and potassium. Hemodialysis does not remove candesartan.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
